A carregar...
Synergistic inhibitory effects of low-dose decitabine in combination with bortezomib in the AML cell line Kasumi-1
In the present study, the ability of the proteasome inhibitor bortezomib (BZ), an oxidative stress-inducing agent, to sensitize acute myeloid leukemia (AML) cells to decitabine (Dacogen(®), DAC; a DNA methyltransferase inhibitor), in terms of cell viability and differentiation, was investigated. Kas...
Na minha lista:
| Publicado no: | Exp Ther Med |
|---|---|
| Main Authors: | , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
D.A. Spandidos
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7812574/ https://ncbi.nlm.nih.gov/pubmed/33488804 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/etm.2021.9628 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|